AAPL354.88-0.48 (-0.14%) ▼|ABBV294.45-0.53 (-0.18%) ▼|ABT107.25-2.04 (-1.87%) ▼|ACN249.95-3.71 (-1.46%) ▼|ADBE238.54+0.94 (+0.40%) ▲|AMAT380.95-14.13 (-3.58%) ▼|AMD585.30+32.40 (+5.86%) ▲|AMGN467.06-1.05 (-0.22%) ▼|AMT189.79-0.45 (-0.24%) ▼|AMZN267.44+1.27 (+0.48%) ▲|AVGO364.36+19.14 (+5.54%) ▲|AXP318.06-5.05 (-1.56%) ▼|BA171.55-2.99 (-1.71%) ▼|BAC50.51-0.16 (-0.32%) ▼|BKNG161.20+0.99 (+0.62%) ▲|BLK1,216.61-9.70 (-0.79%) ▼|BMY62.32-0.59 (-0.94%) ▼|BNY152.79+0.10 (+0.07%) ▲|BRK-B589.83+1.59 (+0.27%) ▲|C124.06-0.15 (-0.12%) ▼|CAT605.28+3.67 (+0.61%) ▲|CL97.90-0.10 (-0.10%) ▼|CMCSA24.80-0.22 (-0.88%) ▼|COF193.60-3.51 (-1.78%) ▼|COP140.06+2.20 (+1.60%) ▲|COST1,092.21+4.60 (+0.42%) ▲|CRM217.57-0.44 (-0.20%) ▼|CSCO102.01+1.25 (+1.24%) ▲|CVS89.79+0.27 (+0.30%) ▲|CVX216.35+3.07 (+1.44%) ▲|DE678.79-12.96 (-1.87%) ▼|DHR232.16-3.15 (-1.34%) ▼|DIS118.23-1.42 (-1.19%) ▼|DUK128.59-0.18 (-0.14%) ▼|EMR166.92-0.14 (-0.08%) ▼|FDX319.30-3.33 (-1.03%) ▼|GD363.07-4.15 (-1.13%) ▼|GE330.86-11.89 (-3.47%) ▼|GEV818.49+10.25 (+1.27%) ▲|GILD167.95-1.78 (-1.05%) ▼|GM86.25-2.65 (-2.98%) ▼|GOOG295.35+4.72 (+1.62%) ▲|GOOGL298.70+5.25 (+1.79%) ▲|GS913.60-13.21 (-1.43%) ▼|HD348.26-3.05 (-0.87%) ▼|HON223.45-4.19 (-1.84%) ▼|IBM244.67-3.55 (-1.43%) ▼|INTC61.20-1.27 (-2.03%) ▼|INTU340.17-2.47 (-0.72%) ▼|ISRG439.89-9.64 (-2.14%) ▼|JNJ283.52+3.11 (+1.11%) ▲|JPM342.82-0.57 (-0.17%) ▼|KO97.44-0.13 (-0.13%) ▼|LIN522.49-4.06 (-0.77%) ▼|LLY1,427.28-10.01 (-0.70%) ▼|LMT604.09-5.96 (-0.98%) ▼|LOW227.46-4.14 (-1.79%) ▼|LRCX233.78-2.10 (-0.89%) ▼|MA652.60-8.13 (-1.23%) ▼|MCD273.63-1.17 (-0.43%) ▼|MDLZ66.56-0.14 (-0.21%) ▼|MDT100.99-0.62 (-0.61%) ▼|META623.61-5.16 (-0.82%) ▼|MMM186.24-2.64 (-1.40%) ▼|MO77.92+0.53 (+0.68%) ▲|MRK146.95-0.23 (-0.16%) ▼|MS189.17-1.44 (-0.76%) ▼|MSFT523.00+1.88 (+0.36%) ▲|MU798.44-12.86 (-1.59%) ▼|NEE85.29-0.70 (-0.81%) ▼|NFLX62.69-1.85 (-2.87%) ▼|NKE37.76-0.56 (-1.46%) ▼|NOW100.66-2.10 (-2.04%) ▼|NVDA166.19-7.54 (-4.34%) ▼|ORCL127.11-1.27 (-0.99%) ▼|PEP142.26-1.68 (-1.17%) ▼|PFE28.83-0.62 (-2.11%) ▼|PG168.03+0.36 (+0.21%) ▲|PLTR171.58-0.82 (-0.48%) ▼|PM196.66+0.31 (+0.16%) ▲|QCOM177.14+0.57 (+0.32%) ▲|RTX198.36-2.93 (-1.46%) ▼|SBUX107.26-2.63 (-2.39%) ▼|SCHW91.72-1.06 (-1.14%) ▼|SO92.47-1.37 (-1.46%) ▼|SPG233.61-1.14 (-0.49%) ▼|T22.18-0.08 (-0.36%) ▼|TMO699.44-18.27 (-2.55%) ▼|TMUS171.03-1.13 (-0.66%) ▼|TSLA397.45+6.63 (+1.70%) ▲|TXN312.48+2.67 (+0.86%) ▲|UBER69.12-1.56 (-2.21%) ▼|UNH405.13+2.19 (+0.54%) ▲|UNP304.20+2.09 (+0.69%) ▲|UPS110.38-2.07 (-1.84%) ▼|USB60.47-0.23 (-0.38%) ▼|V420.31-5.24 (-1.23%) ▼|VZ46.55-0.05 (-0.11%) ▼|WFC85.76-0.04 (-0.05%) ▼|WMT126.19+0.52 (+0.41%) ▲|XOM169.78+3.07 (+1.84%) ▲|AAPL354.88-0.48 (-0.14%) ▼|ABBV294.45-0.53 (-0.18%) ▼|ABT107.25-2.04 (-1.87%) ▼|ACN249.95-3.71 (-1.46%) ▼|ADBE238.54+0.94 (+0.40%) ▲|AMAT380.95-14.13 (-3.58%) ▼|AMD585.30+32.40 (+5.86%) ▲|AMGN467.06-1.05 (-0.22%) ▼|AMT189.79-0.45 (-0.24%) ▼|AMZN267.44+1.27 (+0.48%) ▲|AVGO364.36+19.14 (+5.54%) ▲|AXP318.06-5.05 (-1.56%) ▼|BA171.55-2.99 (-1.71%) ▼|BAC50.51-0.16 (-0.32%) ▼|BKNG161.20+0.99 (+0.62%) ▲|BLK1,216.61-9.70 (-0.79%) ▼|BMY62.32-0.59 (-0.94%) ▼|BNY152.79+0.10 (+0.07%) ▲|BRK-B589.83+1.59 (+0.27%) ▲|C124.06-0.15 (-0.12%) ▼|CAT605.28+3.67 (+0.61%) ▲|CL97.90-0.10 (-0.10%) ▼|CMCSA24.80-0.22 (-0.88%) ▼|COF193.60-3.51 (-1.78%) ▼|COP140.06+2.20 (+1.60%) ▲|COST1,092.21+4.60 (+0.42%) ▲|CRM217.57-0.44 (-0.20%) ▼|CSCO102.01+1.25 (+1.24%) ▲|CVS89.79+0.27 (+0.30%) ▲|CVX216.35+3.07 (+1.44%) ▲|DE678.79-12.96 (-1.87%) ▼|DHR232.16-3.15 (-1.34%) ▼|DIS118.23-1.42 (-1.19%) ▼|DUK128.59-0.18 (-0.14%) ▼|EMR166.92-0.14 (-0.08%) ▼|FDX319.30-3.33 (-1.03%) ▼|GD363.07-4.15 (-1.13%) ▼|GE330.86-11.89 (-3.47%) ▼|GEV818.49+10.25 (+1.27%) ▲|GILD167.95-1.78 (-1.05%) ▼|GM86.25-2.65 (-2.98%) ▼|GOOG295.35+4.72 (+1.62%) ▲|GOOGL298.70+5.25 (+1.79%) ▲|GS913.60-13.21 (-1.43%) ▼|HD348.26-3.05 (-0.87%) ▼|HON223.45-4.19 (-1.84%) ▼|IBM244.67-3.55 (-1.43%) ▼|INTC61.20-1.27 (-2.03%) ▼|INTU340.17-2.47 (-0.72%) ▼|ISRG439.89-9.64 (-2.14%) ▼|JNJ283.52+3.11 (+1.11%) ▲|JPM342.82-0.57 (-0.17%) ▼|KO97.44-0.13 (-0.13%) ▼|LIN522.49-4.06 (-0.77%) ▼|LLY1,427.28-10.01 (-0.70%) ▼|LMT604.09-5.96 (-0.98%) ▼|LOW227.46-4.14 (-1.79%) ▼|LRCX233.78-2.10 (-0.89%) ▼|MA652.60-8.13 (-1.23%) ▼|MCD273.63-1.17 (-0.43%) ▼|MDLZ66.56-0.14 (-0.21%) ▼|MDT100.99-0.62 (-0.61%) ▼|META623.61-5.16 (-0.82%) ▼|MMM186.24-2.64 (-1.40%) ▼|MO77.92+0.53 (+0.68%) ▲|MRK146.95-0.23 (-0.16%) ▼|MS189.17-1.44 (-0.76%) ▼|MSFT523.00+1.88 (+0.36%) ▲|MU798.44-12.86 (-1.59%) ▼|NEE85.29-0.70 (-0.81%) ▼|NFLX62.69-1.85 (-2.87%) ▼|NKE37.76-0.56 (-1.46%) ▼|NOW100.66-2.10 (-2.04%) ▼|NVDA166.19-7.54 (-4.34%) ▼|ORCL127.11-1.27 (-0.99%) ▼|PEP142.26-1.68 (-1.17%) ▼|PFE28.83-0.62 (-2.11%) ▼|PG168.03+0.36 (+0.21%) ▲|PLTR171.58-0.82 (-0.48%) ▼|PM196.66+0.31 (+0.16%) ▲|QCOM177.14+0.57 (+0.32%) ▲|RTX198.36-2.93 (-1.46%) ▼|SBUX107.26-2.63 (-2.39%) ▼|SCHW91.72-1.06 (-1.14%) ▼|SO92.47-1.37 (-1.46%) ▼|SPG233.61-1.14 (-0.49%) ▼|T22.18-0.08 (-0.36%) ▼|TMO699.44-18.27 (-2.55%) ▼|TMUS171.03-1.13 (-0.66%) ▼|TSLA397.45+6.63 (+1.70%) ▲|TXN312.48+2.67 (+0.86%) ▲|UBER69.12-1.56 (-2.21%) ▼|UNH405.13+2.19 (+0.54%) ▲|UNP304.20+2.09 (+0.69%) ▲|UPS110.38-2.07 (-1.84%) ▼|USB60.47-0.23 (-0.38%) ▼|V420.31-5.24 (-1.23%) ▼|VZ46.55-0.05 (-0.11%) ▼|WFC85.76-0.04 (-0.05%) ▼|WMT126.19+0.52 (+0.41%) ▲|XOM169.78+3.07 (+1.84%) ▲|
5.5 C
New York
Friday, November 13, 2026

Tag: year

EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer

OSLO, Norway, June 24, 2025 (GLOBE NEWSWIRE) -- EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial.

Vitafoods Asia 2025 Is Ready to Connect Nutraceutical World This September

BANGKOK, June 24, 2025 /PRNewswire/ -- In an era where consumers are becoming more health-conscious and proactive about their well-being, the nutraceutical industry has...

Hapbee Technologies Inc. Closes 2024 with Record Q4 Device Sales, Global Distribution Partnerships and Strategic Board Appointments

Fueled by a 198% surge in Q4 device sales revenue and a 200% increase in shipments, Hapbee’s revitalized marketing strategy, expanded retail footprint, luxury spa partnerships, and high-profile Board additions have set the stage for accelerated growth heading into 2025.

Organic Growth Will Be a Defining Advantage as Financial Wealth Hits Record-High $305 Trillion

BOSTON, June 24, 2025 /PRNewswire/ -- Global financial wealth surged to a record $305 trillion in 2024, propelled by an 8.1% rise in financial assets...

Sompo announces leadership changes for its Hong Kong Commercial P&C Insurance business

Li Sheung Kin to retire as Chief Executive Officer, Sompo Hong Kong; Alasdair Walker appointed as successor
Li Sheung Kin to retire as Chief Executive Officer, Sompo Hong Kong; Alasdair Walker appointed as successor

FinVolution Announces Global AI Competition Targeting Deepfake Risks

SHANGHAI, June 24, 2025 /PRNewswire/ -- FinVolution Group has officially launched the 2025 FinVolution Global Data Science Competition today, with a spotlight on deepfake...

Monarch Athletic Club: A Longevity Clinic Disguised as an Athletic Club

LOS ANGELES, June 24, 2025 /PRNewswire/ -- Monarch Athletic Club, the Los Angeles-based wellness disruptor delivering physician-led fitness, recovery, diagnostics, and personalized health optimization,...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Open Lending Corporation, Civitas Resources, and Avis Budget and...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Open Lending Corporation (NASDAQ:LPRO), Civitas Resources, Inc. (NYSE: CIVI), and Avis Budget Group, Inc. (NASDAQ:CAR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

LG WINS “GLOBAL INNOVATION AWARD” AT 2025 NISSAN GLOBAL INNOVATION & QUALITY AWARD

Company Recognized for Driving Innovation in In-Vehicle Infotainment SEOUL, South Korea, June 24, 2025 /PRNewswire/ -- LG Electronics (LG), a mobility sector technology leader, has...

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, PepGen, and Tempus and Encourages Investors to Contact...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Vestis Corporation (NYSE:VSTS), PepGen, Inc. (NASDAQ: PEPG), and Tempus AI, Inc. (NASDAQ: TEM). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages...

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Krispy Kreme, Inc. (NASDAQ:DNUT), Strategy Incorporated (NASDAQ:MSTR), Organon & Co. (NYSE:OGN), and Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE

Robbins LLP is Investigating Allegations that Fortrea Holdings, Inc. (FTRE) Misled Investors Regarding the Progress of its Pre-Spin Projects

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYear